Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
The composition of ORAAL is protected by a granted patent in India until November 2033
The composition of ORAAL is protected by a granted patent in India until November 2033
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
New Board of Directors and management team at Suven Pharma also appointed
Subscribe To Our Newsletter & Stay Updated